Skip to main content

Day: February 10, 2023

Smart Pills Technology Market is Projected Surpass USD 3077.22 Million by 2028 by growing at a CAGR of 22% from 2022-2028; Rising Demand for Minimally Invasive Devices for Accurate Therapeutic Treatment Propels Market Growth

SkyQuest’s research on the smart pills technology market presents a comprehensive analysis of the market’s latest trends and growth prospects. The study is based on thoroughly examining reliable and trustworthy data sources and aims to provide a clear picture of the market’s future trajectory. The report focuses on forecasting future market trends, estimating the size of key market segments, and evaluating the growth potential of regional markets Westford USA, Feb. 10, 2023 (GLOBE NEWSWIRE) — North America is the prominent region in the global smart pills technology market, thanks to favorable reimbursement policies and streamlined regulatory processes for capsule endoscopy. As per SkyQuest’s findings, there is a growing need for smart pills in the region, particularly in the United States, owing to the...

Continue reading

Biopharmaceutical Analytical Testing Services Market is anticipated to Cross USD 11.67 Billion by 2028 with a CAGR of 6.36% during 2022 – 2028; Huge Rise in Outsourcing of Analytical Testing Services Emerges as the Key Trend

SkyQuest’s latest market research report is a valuable resource for businesses seeking a competitive edge in the biopharmaceutical analytical testing services market. The report offers in-depth insights into the latest market trends, demographic changes, and customer preferences, helping companies to make informed marketing decisions. With the market being highly competitive, it’s essential to have a well-informed marketing strategy to succeed. The report provides valuable information that can be used to form a sound marketing plan and implement effective strategies. Westford USA, Feb. 10, 2023 (GLOBE NEWSWIRE) — North America’s biopharmaceutical analytical testing services market has seen significant growth in recent years. Such growth is driven by the increasing use of FTE (full-time equivalent) agreements for...

Continue reading

Medical Practice Management Software Market is Poised to Reach USD 23.46 Billion by 2028 with a CAGR of over 8.8% from 2022-2028; Growing Demand for Improved Healthcare Provisions to Boost the Market Growth

The medical practice management software market is a rapidly growing industry, and it is crucial for market participants and stakeholders to stay informed about the latest trends and developments. This is where the recent research study from SkyQuest can be of great assistance. The research report provides comprehensive data on market segments, sub-segments, and geographies, helping players understand the market landscape better. As a result, the study can help market players make informed decisions about product optimization, targeted regions, and supply chain solutions, ultimately leading to increased market share and revenue growth. Westford USA, Feb. 10, 2023 (GLOBE NEWSWIRE) — The North American region has seen a significant increase in medical practice management software (MPMS) adoption in recent years. Such progress can...

Continue reading

According to MarketsandMarkets™ Report – The Cell Culture Market is Anticipated to Achieve $41.3 billion by 2026

Chicago, Feb. 10, 2023 (GLOBE NEWSWIRE) — As per the new market research report published by MarketsandMarkets, “Cell Culture Market Size, Growth by Product (Consumables (Media, Serum, Reagent, Vessels), Equipment (Bioreactor, Centrifuge, Incubator)), Application (Vaccines, mAbs, Diagnostics, Tissue Engineering), End User (Pharma, Biotech, Hospital) – Global Forecast to 2026“, the global Cell Culture market in terms of revenue was estimated to be worth $22.8 billion in 2021 and is poised to reach $41.3 billion by 2026, growing at a CAGR of 12.6% from 2021 to 2026. Browse in-depth TOC on “Cell Culture Market“334 – Tables48 – Figures398 – Pages Download an Illustrative Overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=559 Cell Culture Market Report Scope:Report Coverage...

Continue reading

Ayala Pharmaceuticals Reports Financial Results For the Fiscal Year Ended October 31, 2022

REHOVOT, Israel and MONMOUTH JUNCTION, N.J., Feb. 10, 2023 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (f/k/a Advaxis Inc.) (the “Company,” “New Ayala,” “we,” “us” or “our”) (OTCQX: ADXS), a clinical-stage oncology company, today announces financial results for the fiscal year ended October 31, 2022. Management Commentary “We were pleased to close our previously announced merger in January 2023,” said Kenneth A. Berlin, President and Chief Executive Officer of the Company. “Our immediate priorities include executing on Part B of the ongoing registration-enabling RINGSIDE study evaluating AL102 in desmoid tumors. We believe that AL102 has best in class potential and, if approved, may have important clinical advantages including safety, convenient once daily dosing and lower pill burden. For AL101, we expect to gain clarity this...

Continue reading

REMINDER – Saputo Inc.: Fiscal 2023 Third Quarter Results

MONTREAL, Feb. 10, 2023 (GLOBE NEWSWIRE) — Saputo Inc. (TSX:SAP) – Saputo will release its fiscal 2023 third quarter financial results on Thursday, February 9, 2023. A press release will be issued after markets close, and a conference call is scheduled on Friday, February 10, 2023, at 8:30 a.m. (Eastern Time) to discuss the Company’s results. The webcast will begin with a short presentation followed by a question and answer period. The speakers will be Mr. Lino A. Saputo, Chair of the Board, President and Chief Executive Officer and Mr. Maxime Therrien, Chief Financial Officer and Secretary. To participate:Webcast: https://www.gowebcasting.com/12421Presentation slides will be included in the webcast and can also be accessed in the “Investors” section of Saputo’s website (www.saputo.com), under “Calendar of Events”.Conference...

Continue reading

Gencor Releases First Quarter Fiscal 2023 Results

ORLANDO, Fla., Feb. 10, 2023 (GLOBE NEWSWIRE) — Gencor Industries, Inc. (the “Company” or “Gencor”) (NYSE American: GENC) announced today net revenues increased 28.4% to $25,825,000 for the quarter ended December 31, 2022 compared to $20,106,000 for the quarter ended December 31, 2021, due to higher contract equipment and parts sales. Gross margins were 22.5% for the quarter ended December 31, 2022 compared to 18.4% for the quarter ended December 31, 2021 on increased production and favorable price realization. Product engineering and development expenses decreased $452,000 to $897,000 for the quarter ended December 31, 2022, as compared to $1,349,000 for the quarter ended December 31, 2021, due primarily to lower headcount. Selling, general and administrative (“SG&A”) expenses decreased by $600,000 to $2,799,000 for the quarter...

Continue reading

Fortis Inc. Reports Fourth Quarter & Annual 2022 Results

ST. JOHN’S, Newfoundland and Labrador, Feb. 10, 2023 (GLOBE NEWSWIRE) — Fortis Inc. (“Fortis” or the “Corporation”) (TSX/NYSE: FTS), a well-diversified leader in the North American regulated electric and gas utility industry, released its 2022 fourth quarter and annual financial results1. HighlightsReported net earnings of $1.3 billion, or $2.78 per common share in 2022 Adjusted net earnings per common share2 of $2.78, up from $2.59 in 2021, representing ~7% annual EPS growth Capital expenditures2 of $4.0 billion, with over $600 million focused on delivering cleaner energy, yielding ~7% rate base growth3 Scope 1 emissions 28% below 2019 levels; 75% emissions reduction by 2035 target on track in support of 2050 net-zero goal Capital structure complaint filed against ITC Midwest denied by FERC“2022...

Continue reading

Barnwell Industries, Inc. Reports Earnings for its First Quarter Ended December 31, 2022 and the Declaration of a Cash Dividend

Solid Start to the Year Led by Oil & Gas Segment HONOLULU, Feb. 10, 2023 (GLOBE NEWSWIRE) — Barnwell Industries, Inc. (NYSE American: BRN) today reported net earnings of $1,089,000, $0.11 per share, for the three months ended December 31, 2022, as compared to net earnings of $1,073,000, $0.11 per share, for the three months ended December 31, 2021. Mr. Alexander C. Kinzler, Chief Executive Officer of Barnwell, commented, “We are pleased to report that our first quarter oil and gas segment revenues increased by over $1,300,000 (33%) as prices increased for all products with oil, natural gas, and natural gas liquids increasing 6%, 4%, and 42%, respectively. Net oil production increased to 48,000 Bbls (barrels) from 39,000 Bbls (23%) and net natural gas production increased to 300,000 Mcf (1,000 cubic feet) from 205,000 Mcf (46%),...

Continue reading

Municipality Finance Plc Financial Statements Bulletin 1 January–31 December 2022

Municipality Finance PlcFinancial Statements Bulletin10 February 2023 at 1:00 pm (EET) Municipality Finance Plc Financial Statements Bulletin 1 January–31 December 2022 In brief: MuniFin Group in 2022The Group’s net operating profit excluding unrealised fair value changes amounted to EUR 170 million (EUR 213 million). As expected, it decreased from the comparison year’s exceptionally good result and was 20.0% lower than in the year before (8.0% growth in 2021). This drop was influenced by the change in credit terms applied in late 2021 for the benefit of the Group’s customers. The Group’s net interest income totalled EUR 241 million (EUR 280 million) in January–December. Costs in the financial year amounted to EUR 73 million (EUR 72 million). Costs excluding non-recurring items totalled EUR 69 million (EUR 61 million] and making the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.